Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers C > Headlines for CytRx Corp. > News item |
CytRx given an extra 180 days to comply with Nasdaq listing requirements
New York, Dec. 6 - CytRx Corp. said the Nasdaq Stock Market has allowed it an additional 180 days to regain compliance with the Nasdaq Capital Market's $1.00 minimum bid price requirement.
The extension runs until June 2, 2006.
CytRx is a Los Angeles-based biopharmaceutical research and development company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.